Selonsertib Enhances Kidney Protection Beyond Standard of Care in a Hypertensive, Secondary Glomerulosclerosis CKD Model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selonsertib Enhances Kidney Protection Beyond Standard of Care in a Hypertensive, Secondary Glomerulosclerosis CKD Model

Published:2022-07-28 Issue:7 Volume:3 Page:1169-1182
ISSN:2641-7650
Container-title:Kidney360
language:en
Short-container-title:Kidney360

Author:

Badal Shawn S.,Al Tuhaifi Tareq,Yu Ya-Fen,Lopez David,Plato Craig T.,Joly Kristin,Breckenridge David G.,Yang Hai-Chun,Liles John T.,Fogo Agnes B.

Funder

Gilead Sciences

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference38 articles.

1. Models of chronic kidney disease;Yang;Drug Discov Today Dis Models,2010

2. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis;Naito;Am J Physiol Renal Physiol,2010

3. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1;Ma;J Am Soc Nephrol,2005

4. Mechanisms of disease reversal in focal and segmental glomerulosclerosis;Yang;Adv Chronic Kidney Dis,2014

5. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis;Tobiume;EMBO Rep,2001

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selonsertib in Patients with Diabetic Kidney Disease;Journal of the American Society of Nephrology;2024-07-17

2. Targeting ASK1 by CS17919 alleviates kidney‐ and liver‐related diseases in murine models;Animal Models and Experimental Medicine;2024-06-14

3. Therapieoptionen bei diabetischer Nephropathie;Die Diabetologie;2023-02-21

4. ASK1 Inhibitor in Chronic Kidney Disease Therapy: From Bench to Bedside;Kidney360;2022-07-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3